Editorial: The Emerging Role of Artificial Intelligence in Dermatology

Mahmood, Farhan; Bendayan, Solomon; Ghazawi, Feras M.; Litvinov, Ivan V.

doi:10.3389/fmed.2021.751649

Cited by 7 publications

(2 citation statements)

References 67 publications

(68 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…23 All these diverse applications of AI in dermatology are announced to optimize patient care inside and outside the clinical workflow. [25][26][27] Historically, AI in dermatology was centred on skin cancer detection, 5 and ever since, it has expanded to other diseases such as eczema and psoriasis. 1 As a leader in AI research in dermatology, skin cancer is one of the most advanced field going beyond clinical usage.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The State of Artificial Intelligence in Skin Cancer Publications

Joly-Chevrier,

Nguyen,

Liang

et al. 2024

J Cutan Med Surg

View full text Add to dashboard Cite

Background: Artificial intelligence (AI) in skin cancer is a promising research field to assist physicians and to provide support to patients remotely. Physicians’ awareness to new developments in AI research is important to define the best practices and scope of integrating AI-enabled technologies within a clinical setting. Objectives: To analyze the characteristics and trends of AI skin cancer publications from dermatology journals. Methods: AI skin cancer publications were retrieved in June 2022 from the Web of Science. Publications were screened by title, abstract, and keywords to assess eligibility. Publications were fully reviewed. Publications were divided between nonmelanoma skin cancer (NMSC), melanoma, and skin cancer studies. The primary measured outcome was the number of citations. The secondary measured outcomes were articles’ general characteristics and features related to AI. Results: A total of 168 articles were included: 25 on NMSC, 77 on melanoma, and 66 on skin cancer. The most common types of skin cancers were melanoma (134, 79.8%), basal cell carcinoma (61, 36.3%), and squamous cell carcinoma (45, 26.9%). All articles were published between 2000 and 2022, with 49 (29.2%) of them being published in 2021. Original studies that developed or assessed an algorithm predominantly used supervised learning (66, 97.0%) and deep neural networks (42, 67.7%). The most used imaging modalities were standard dermoscopy (76, 45.2%) and clinical images (39, 23.2%). Conclusions: Most publications focused on developing or assessing screening technologies with mainly deep neural network algorithms. This indicates the eminent need for dermatologists to label or annotate images used by novel AI systems.

show abstract